Detalles de la búsqueda
1.
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Lancet
; 397(10274): 581-591, 2021 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33581820
2.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32580883
3.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779963
4.
Real-world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancer.
BJU Int
; 121(2): 268-274, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28940952
5.
Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer.
BJU Int
; 119(5): 667-675, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27753182
6.
Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09).
Lancet Oncol
; 14(4): 306-16, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23465742
7.
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
J Clin Oncol
; 38(28): 3261-3272, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32663119
8.
Board-certified specialty training program in radiation oncology in a war-torn country: Challenges, solutions and outcomes.
Clin Transl Radiat Oncol
; 19: 46-51, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31497656
9.
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.
Eur Urol
; 69(6): 1016-25, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26707868
10.
Role of second-line systemic treatment post-docetaxel in metastatic castrate resistant prostate cancer- current strategies and future directions.
Anticancer Agents Med Chem
; 11(3): 296-306, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21426298
11.
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).
Radiother Oncol
; 100(1): 93-100, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21752481
Resultados
1 -
11
de 11
1
Próxima >
>>